Citations

Showing 10 of 108119 citations.

The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study
Duarte‐García, Alí , Pham, Michael M., Crowson, Cynthia S. , Amin, Shreyasee , Moder, Kevin G., Pruthi, Rajiv K. , Warrington, Kenneth J. , Matteson, Eric L. , Pham, Michael M. , Duarte-García, Alí , Warrington, Kenneth J , Pham, Michael M.

Mayo Clinic

Arthritis & Rheumatology | April 8, 2019 | Volume: 71 | Issue: 9 | Pages: 1545-1552

10.1002/art.40901 | PMID 30957430 Get It

Objective To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome ( APS ). Methods An inception cohort of patients with incident APS in 2000–2015 from a geographically well‐defined population was identified based on comprehensive individual medical records review. All cases met the 2006 Sydney criteria for APS (primary definition) or had a diagnosis of APS confirmed by physician consensus (secondary definition). Levels of lupus anticoagulant, IgM and IgG anticardiolipin antibodies, and anti–β2‐glycoprotein I antibodies were tested in a centralized laboratory. Incidence rates were age‐ and sex‐adjusted to the 2010 US white population. Prevalence estimates were obtained from the incidence rates, assuming that there was no increased mortality associated with APS and that migration in or out of the area was independent of disease status. Results Among this cohort in 2000–2015, 33 cases of incident APS , as defined by the Sydney criteria, were identified (mean age of patients 54.2 years; 55% female, 97% white). The annual incidence of APS in adults ages ≥18 years was 2.1 (95% confidence interval [95% CI ] 1.4–2.8) per 100,000 population. Incidence rates were similar in both sexes. The estimated prevalence of APS was 50 (95% CI 42–58) per 100,000 population, and was similar in both sexes. Six patients (18%) had a concurrent diagnosis of systemic lupus erythematosus. The most frequent clinical manifestation was deep vein thrombosis. The overall frequency of mortality among patients with APS was not significantly different from that in the general population (standardized mortality ratio 1.61, 95% CI 0.74–3.05). Conclusion APS occurred in ~2 persons per 100,000 population per year. The estimated prevalence was 50 per 100,000 population. Overall mortality was not notably different from that observed in the general population.
Vasovagal-Mediated Emergency From a Left Internal Carotid Aneurysm
Peacock, Sarah , Peel, Jeffrey B. , Farres, Houssam , Miller, David A. , Ng, Lauren , Peel, J Brent, Freeman, W David, Freeman, William D.

Mayo Clinic

The Neurohospitalist | April 8, 2019 | Volume: 10 | Issue: 1 | Pages: 69-70

10.1177/1941874419840879 | PMID 31839870 Get It

SEGMENTAL DIFFUSE VASCULAR LEAKAGE: A FLUORESCEIN ANGIOGRAPHIC FINDING IN PATIENTS WITH VON HIPPEL–LINDAU DISEASE
Deák, Gábor , Pulido, José S. , Jampol, Lee M. , Deák, Gabor Gy

Mayo Clinic

RETINAL Cases & Brief Reports | April 8, 2019 | Volume: 15 | Issue: 5 | Pages: 628-631

10.1097/icb.0000000000000868 | PMID 30932993 Get It

Purpose: To describe a novel fluorescein angiographic finding in patients with von Hippel–Lindau disease. Methods: Retrospective case series of patients diagnosed with retinal capillary hemangioblastoma (RCH) in the setting of von Hippel–Lindau. Results: We identified six eyes of three patients with von Hippel–Lindau and leaky retinal vessels. All eyes showed segmental diffuse vascular leakage (SDVL) that was seen in the late phase of the angiogram and that originated from third order and more peripheral retinal veins and adjacent capillaries. These vessels did not drain from the RCHs. Segmental diffuse vascular leakage was mainly seen in the mid and far periphery. In some cases, it was located near the RCHs, while in other cases, it was remote. Segmental diffuse vascular leakage was also seen in one eye without RCHs. On follow-up, the extent and intensity of segmental diffuse vascular leakage did not change after the RCHs were treated with laser or cryotherapy. Conclusion: Diffuse vascular leakage from retinal venules around and away from RCHs in patients with von Hippel–Lindau disease is seen, but the clinical and prognostic importance of this finding is uncertain.
Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing Multi-Modality Imaging
Arsanjani, Reza , Agasthi, Pradyumna , Ahn, Daniel H. , Mookadam, Farouk , Yang, Ming , Yang, Ming , Arsanjani, Reza

Mayo Clinic

Korean Circulation Journal | April 8, 2019 | Volume: 49 | Issue: 6 | Pages: 557

10.4070/kcj.2018.0367 | PMID 31074227 Get It

Meta-Analysis and Evidence Base for the Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells in Knee Cartilage Repair: Methodological Guidelines and Quality Assessment
Awad, Mohamed E. , Abdelsamid, Mohamed Farouk, Aguilar‐Perez, Alexandra, Mohsen, Ibrahim , Hunter, Monte, Hamrick, Mark W. , Isales, Carlos M. , Elsalanty, Mohammed , Hill, William , Fulzele, Sadanand , Elsisy, Mohamed F. , Abdelsamid, Mohamed F, Hamrick, Mark W , Hill, William D , Fulzele, Sadanand , Hussein, Khaled A. , Helwa, Inas

Mayo Clinic

Stem Cells International | April 7, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-15

10.1155/2019/3826054 | PMID 31089328 Get It

The aim of this study is to review all the published clinical trials on autologous bone marrow mesenchymal stem cells (BM-MSCs) in the repair of cartilage lesions of the knee. We performed a comprehensive search in three electronic databases: PubMed, Medline via Ovid, and Web of Science. A systematic review was conducted according to the guidelines of PRISMA protocol and the Cochrane Handbook for Systematic Reviews of Interventions. The modified Coleman methodology score was used to assess the quality of the included studies. Meta-analysis was conducted to estimate the effect size for Pain and function change after receiving BM-MSCs. Thirty-three studies—including 724 patients of mean age 44.2 years—were eligible. 50.7% of the included patients received cultured BM-MSCs for knee cartilage repair. There was improvement in the MINORS quality score over time with a positive correlation with the publication year. Meta-analysis indicated better improvement and statistical significance in the Visual Analog Scale for Pain, IKDC Function, Tegner Activity Scale, and Lysholm Knee Score after administration of noncultured BM-MSCs when compared to evaluation before the treatment. Meanwhile, there was a clear methodological defect in most studies with an average modified Coleman methodology score (MCMS) of 55. BM-MSCs revealed a clinically relevant improvement in pain, function, and histological regeneration.
Detection of multicentric breast cancer using dedicated breast PET
Hunt, Katie N. , Swanson, Tiffinee N. , O’Connor, Michael K. , Sandhu, Nicole P. , Swanson, Tiffinee , O'Connor, Michael K

Mayo Clinic

The Breast Journal | April 7, 2019 | Volume: 25 | Issue: 3 | Pages: 512-514

10.1111/tbj.13270 | PMID 30955230 Get It

An under‐recognized high‐risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application
Lane, Colleen E. , Eleid, Mackram F. , Holmes, David R.

Mayo Clinic

Catheterization and Cardiovascular Interventions | April 6, 2019 | Volume: 94 | Issue: 2 | Pages: 274-279

10.1002/ccd.28220 | PMID 30953408 Get It

AbstractObjectiveIdentify patients undergoing transcatheter mitral valve repair (TMVR) who could potentially benefit from alternative ischemic stroke prophylaxis utilizing a left atrial appendage closure (LAAC) device.BackgroundPatients undergoing TMVR have a high incidence of atrial fibrillation (AF). The co‐morbidities which qualify them to undergo TMVR also increase their risk of stroke and bleeding, making stroke prophylaxis problematic.MethodsWe conducted a single‐center retrospective study, in which the bleeding and stroke risk of all patients undergoing TMVR for degenerative mitral valve disease were reviewed to determine candidacy for a LAAC device for stroke prevention as an alternative to chronic anticoagulation.ResultsAF was present in 122 (62%) of TMVR patients with an average CHA2DS2‐VASc score of 3.99. 23% of TMVR patients had a history of prior major bleeding event, predominately gastrointestinal bleed. Fifty‐three and 47% of TMVR patients were at high or intermediate risk of bleeding, respectively, according to their HAS‐BLED score. 50% of patients undergoing TMVR would qualify for LAAC device based on risk assessments.ConclusionPatients undergoing TMVR represent a high risk group of AF patients that may benefit from a LAAC device.
Telocytes express ANO‐1‐encoded chloride channels in canine ventricular myocardium
Pinilla, Pedro J Gomez, Beyder, Arthur, Farrugia, Gianrico , Asirvatham, Samuel J. , Gomez Pinilla, Pedro J, Kapa, Suraj , Asirvatham, Samuel J , DeSimone, Christopher V. , McLeod, Christopher J. , Kapa, Suraj

Mayo Clinic

Journal of Arrhythmia | April 6, 2019 | Volume: 35 | Issue: 3 | Pages: 515-521

10.1002/joa3.12176 | PMID 31293701 Get It

AbstractIntroductionIt is unknown if ANO‐1 is expressed in the heart, though the presence of a calcium‐activated chloride current has been proposed to mediate some cardiac dysrhythmias. Furthermore, a specific cell type termed telocytes, morphologically mimicking Cajal cells which use ANO‐1 to modulate their pacemaker activity in the gut, have been described in the heart. We therefore sought to determine whether this channel is expressed in the canine heart.MethodsMyocardium was sampled from the ventricles of five canines. Sections were labeled with anti‐Kit and anti‐ANO‐1 antibodies. Slides were reviewed by four investigators looking at cell morphology, distribution, and co‐localization. Identification of telocytes was based on criteria including morphology, Kit positivity (+), and ANO‐1 positivity (+).ResultsClusters of cells meeting criteria for telocytes were seen in the epicardium, sub‐epicardium, and mid‐myocardium. A small subset of cells that were morphologically similar to myocytes was ANO‐1 (+) but Kit (−). In total, three different cell classes were found: (i) Kit (+), ANO‐1 (+) cells with the appearance of telocytes; (ii) Kit (+), ANO‐1 (−) cells; and (iii) Kit (−), ANO‐1 (+) cells with the morphologic appearance of cardiac myocytes.ConclusionsTelocytes are present in the canine ventricle and express ANO‐1. These data merit further study to elucidate the functional expression of these channels in the heart and whether they may be targets for cardiac arrhythmias.
INCREASED INCIDENCE OF CUTANEOUS KERATINOCYTIC AND MELANOCYTIC MALIGNANCIES IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
Shah, Saumya M. , Starr, Matthew R. , Comfere, Nneka I. , AbouChehade, Jackson E., Hodge, David O. , Iezzi, Raymond , Bakri, Sophie J. , Starr, Matthew R , Dalvin, Lauren A.

Mayo Clinic

Retina | April 6, 2019 | Volume: 40 | Issue: 5 | Pages: 857-865

10.1097/iae.0000000000002506 | PMID 30986797 Get It

Purpose: The relationship between age-related macular degeneration (AMD) and malignancy, especially cutaneous malignancies, is not well studied. We investigated a possible association between AMD and cutaneous malignancies. Methods: A retrospective, consecutive review of all patients who had received at least 1 intravitreal injection for wet AMD between January 1, 2004, and December 31, 2013, was conducted using the Rochester Epidemiology Project in Olmsted County, Minnesota. Age- and sex-matched control groups included 473 pre–anti–vascular endothelial growth factor era wet AMD patients, 504 concurrent time dry AMD patients, and 504 patients with no AMD. The rates of AMD and overall malignancy, cutaneous malignancies, and specific types of cutaneous malignancies were compared between groups of patients. Results: Patients with wet AMD incurred an increased rate of overall malignancies compared to patients with dry AMD {52.8% wet AMD (confidence interval [CI]: 48.3–57.2) vs. 43.7% dry AMD (CI: 39.3–48.1); P= 0.003} or those without AMD (52.8% wet AMD [CI: 48.3–57.2] vs. 35.3% no AMD [CI: 31.1–39.7]; P = <0.001). Patients with dry AMD also had higher rates of malignancy than those without AMD (43.7% dry AMD [CI: 39.3–48.1] vs. 35.3% no AMD [CI: 31.1–39.7]; P = 0.007). Rate of cutaneous malignancies was increased in patients with wet AMD compared to patients with dry AMD (24.4% wet AMD [CI: 20.7–28.4] vs. 14.6% dry AMD [CI: 11.5–17.9]; P = <0.001) and those with no AMD (24.4% wet AMD [CI: 20.7–28.4] vs. 9.7% no AMD [CI: 7.3–12.7]; P = <0.001). Conclusion and Relevance: To the best of our knowledge, this is the first report to establish an association between AMD and cutaneous malignancies, supporting a possible discussion of the association when a patient presents with one of the two conditions.
Percutaneous “biopsy” of biopsy clips: A commentary on our initial experience
Samreen, Naziya , Lee, Christine U. , Sandhu, Nicole P. , Ghosh, Karthik, Lee, Christine , Sandhu, Nicole

Mayo Clinic

The Breast Journal | April 6, 2019 | Volume: 25 | Issue: 3 | Pages: 552-554

10.1111/tbj.13264 | PMID 30953372 Get It